PTH and Hypercalcemia: The consensus statements from the first PARAT workshop, a new European Society of Endocrinology program, aiming to identify unmet scientific and educational needs of parathyroid disorders, held in September 2018, highlighted that evidence concerning the natural history of PHPT and whether morbidity and long-term outcomes are related to hypercalcemia or plasma PTH concentrations, or both, is yet sparse [9].